Search
Search Results
-
Lipoprotein(a): what clinicians need to know
177PDF: 375HTML: 18 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
669PDF: 1960Supplementary: 284Appendix: 230 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
710PDF: 172Supplementary: 134Appendix: 106HTML: 8 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
97PDF: 185Supplementary: 135HTML: 12 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
714PDF: 166Supplementary: 144Appendix: 103HTML: 11 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
929PDF: 488Appendix: 133HTML: 5 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1031pdf: 217Supplementary Material: 35HTML: 91 -
Epidemiology of peripartum cardiomyopathy in Africa
2147PDF: 476HTML: 59 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3258PDF: 480Appendix: 366HTML: 20 -
Modulation of cardiac metabolism in heart failure
2288PDF: 1111HTML: 6 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1842PDF: 491SUPPLEMENTARY MATERIAL: 291GRAPHICAL ABSTRACT: 258HTML: 5 -
-
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1066PDF: 229Supplementary: 150HTML: 74 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2192PDF: 372Appendix B: 425Appendix A: 313HTML: 2 -

